Lakhanpal Rohit R, Humayun Mark S, de Juan Eugene, Lim Jennifer I, Chong Lawrence P, Chang Tom S, Javaheri Michael, Fujii Gildo Y, Barnes Aaron C, Alexandrou Terry J
Doheny Retina Institute, Doheny Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.
Ophthalmology. 2005 May;112(5):817-24. doi: 10.1016/j.ophtha.2004.11.053.
To evaluate the safety and efficacy of 25-gauge instrumentation for a variety of vitreoretinal conditions on previously nonvitrectomized eyes.
Single-center, retrospective, interventional case series.
One-hundred forty eyes of 140 patients were evaluated at the Doheny Retina Institute from July 2002 to July 2003.
All patients underwent surgical procedures using the Millennium 25-gauge Transconjunctival Standard Vitrectomy system. Twenty eyes (14.3%) underwent procedures without vitrectomy.
Postoperative visual acuity (VA), intraocular pressure, surgical time, postoperative inflammation, complications, and number of sutured sites.
No intraoperative complications were noted. No cases required conversion to 20-gauge machines. Ten cases (7.1%) involved single-site sclerotomy suture placement due to bleb formation at the conclusion of the procedure, but 5 of these entry sites were enlarged to facilitate larger instrumentation for tissue manipulation. Median VA improved from 20/250 (logarithm of the minimum angle of resolution, 1.08+/-0.47) preoperatively to 20/60 (0.47+/-0.30) (P<0.0001) at final visit. Mean follow-up was 33.8+/-9.7 weeks, and all eyes were observed for a minimum of 12 weeks. Mean total surgical time was 17.4+/-6.9 minutes. Intraocular pressures remained stable throughout the postoperative course. Five eyes (3.8%) presented on day 1 with shallow choroidal detachments, but all resolved by day 7, and none required volume infusion during the postoperative period. All but one of these cases was within the first 50 procedures performed. No detectable inflammation was noted in any eyes by 4 weeks postoperatively. No case of retinal detachment or endophthalmitis was recorded.
Transconjunctival surgery using 25-gauge instrumentation may hasten postoperative recovery by decreasing overall surgical time and postoperative inflammation. Procedures requiring minimal intraocular manipulation did not require sutures and, thus, may be better suited for this surgical modality.
评估25G手术器械用于多种玻璃体视网膜疾病的未行过玻璃体切割术的眼的安全性和有效性。
单中心、回顾性、干预性病例系列研究。
2002年7月至2003年7月在多尼视网膜研究所对140例患者的140只眼进行了评估。
所有患者均使用千禧25G经结膜标准玻璃体切割系统进行手术。20只眼(14.3%)未行玻璃体切割术。
术后视力(VA)、眼压、手术时间、术后炎症、并发症及缝合部位数量。
术中未发现并发症。无一例需要更换为20G手术器械。10例(7.1%)因手术结束时形成水泡而进行了单部位巩膜切开缝合,但其中5个进入部位扩大以利于使用更大的器械进行组织操作。末次随访时,中位视力从术前的20/250(最小分辨角对数,1.08±0.47)提高到20/60(0.47±0.30)(P<0.0001)。平均随访时间为33.8±9.7周,所有眼均至少观察12周。平均总手术时间为17.4±6.9分钟。术后眼压在整个病程中保持稳定。5只眼(3.8%)在术后第1天出现脉络膜脱离,但均在第7天消退,术后无一例需要进行液体输注。除1例之外,所有这些病例均在最初的50例手术之内。术后4周时,所有眼中均未发现可检测到的炎症。未记录到视网膜脱离或眼内炎病例。
使用25G手术器械的经结膜手术可通过缩短总手术时间和减少术后炎症来加速术后恢复。需要最少眼内操作的手术不需要缝合,因此可能更适合这种手术方式。